| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/16/2023 | 124.44% | Leerink Partners | → $9 | Initiates Coverage On | → Outperform |
| 09/26/2023 | 299% | Cantor Fitzgerald | → $16 | Reiterates | Overweight → Overweight |
| 08/22/2023 | 299% | Cantor Fitzgerald | → $16 | Reiterates | Overweight → Overweight |
| 05/10/2023 | 398.75% | JMP Securities | → $20 | Reiterates | → Market Outperform |
| 03/28/2023 | 274.06% | Canaccord Genuity | → $15 | Reiterates | → Buy |
| 03/15/2023 | 398.75% | JMP Securities | → $20 | Reiterates | → Market Outperform |
| 11/11/2022 | 274.06% | Jefferies | → $15 | Assumes | → Buy |
| 05/09/2022 | 274.06% | Canaccord Genuity | $10 → $15 | Upgrades | Hold → Buy |
| 05/05/2022 | 249.13% | SVB Leerink | $12 → $14 | Maintains | Outperform |
| 11/04/2021 | 398.75% | JMP Securities | $25 → $20 | Maintains | Market Outperform |
| 05/06/2021 | 498.5% | Canaccord Genuity | $21 → $24 | Maintains | Hold |
| 02/23/2021 | 423.69% | Canaccord Genuity | $20 → $21 | Maintains | Hold |
| 02/23/2021 | 573.32% | SVB Leerink | $23 → $27 | Maintains | Outperform |
| 10/23/2020 | 498.5% | Guggenheim | → $24 | Initiates Coverage On | → Buy |
| 08/06/2020 | 286.53% | SVB Leerink | $13.5 → $15.5 | Maintains | Outperform |
| 05/07/2020 | 199.25% | Canaccord Genuity | → $12 | Downgrades | Buy → Hold |
| 04/02/2020 | — | BTIG | Downgrades | Buy → Neutral | |
| 11/07/2019 | 523.44% | Canaccord Genuity | $30 → $25 | Maintains | Buy |
| 11/07/2019 | 373.82% | Cantor Fitzgerald | $21 → $19 | Maintains | Overweight |
| 08/07/2019 | — | William Blair | Downgrades | Outperform → Market Perform | |
| 03/25/2019 | 598.25% | BTIG | → $28 | Upgrades | Neutral → Buy |
| 11/14/2018 | — | BTIG | Initiates Coverage On | → Neutral | |
| 10/30/2018 | 972.32% | Cantor Fitzgerald | $45 → $43 | Maintains | Overweight |
What is the target price for Axogen (AXGN)?
The latest price target for Axogen (NASDAQ: AXGN) was reported by Leerink Partners on October 16, 2023. The analyst firm set a price target for $9.00 expecting AXGN to rise to within 12 months (a possible 124.44% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Axogen (AXGN)?
The latest analyst rating for Axogen (NASDAQ: AXGN) was provided by Leerink Partners, and Axogen initiated their outperform rating.
When is the next analyst rating going to be posted or updated for Axogen (AXGN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Axogen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Axogen was filed on October 16, 2023 so you should expect the next rating to be made available sometime around October 16, 2024.
Is the Analyst Rating Axogen (AXGN) correct?
While ratings are subjective and will change, the latest Axogen (AXGN) rating was a initiated with a price target of $0.00 to $9.00. The current price Axogen (AXGN) is trading at is $4.01, which is within the analyst's predicted range.